Cardiovascular Magnetic Resonance: Deeper Insights Through Bioengineering: Figure 3: Rest – Video

Posted on by


Cardiovascular Magnetic Resonance: Deeper Insights Through Bioengineering: Figure 3: Rest
Figure 3 from the 2013 review by A.A. Young and J.L. Prince, "Cardiovascular Magnetic Resonance: Deeper Insights Through Bioengineering," from the Annual Rev...

By: Annual Reviews Extra

Follow this link:
Cardiovascular Magnetic Resonance: Deeper Insights Through Bioengineering: Figure 3: Rest - Video

Cardiovascular Magnetic Resonance: Deeper Insights Through Bioengineering: Figure 6 – Video

Posted on by


Cardiovascular Magnetic Resonance: Deeper Insights Through Bioengineering: Figure 6
Figure 6 from the 2013 review by A.A. Young and J.L. Prince, "Cardiovascular Magnetic Resonance: Deeper Insights Through Bioengineering," from the Annual Rev...

By: Annual Reviews Extra

Visit link:
Cardiovascular Magnetic Resonance: Deeper Insights Through Bioengineering: Figure 6 - Video

Berkeley engineers join $24 million push for craniofacial repair therapies – UC Berkeley

Posted on by

Kevin Healy, professor of bioengineering and materials science and engineering, leads Berkeleys role in a new craniofacial research center, C-DOCTOR.

UC Berkeleyis part ofa California-based, six-university consortium that has beenawarded $12 million by the National Institutes of Healthto develop strategies for treating craniofacial defects, which affect millions of Americans.

The consortium, called the Center for Dental, Oral and Craniofacial Tissue and Organ Regeneration (C-DOCTOR), is a part of a broader $24 million effort to develop resources and strategies for regenerating dental, oral and craniofacial tissues that have been damaged by disease or injury.

Craniofacial defects have devastating effects on patients, both because vital sensory organs and brain are housed in the cranium and because the face is so important to a persons identity. Such defects also can lead to compromised general health.

C-DOCTORs goal isto shepherd new therapies through preliminary studies and into human clinical trials. Funding for C-DOCTOR comes from the NIHs National Institute of Dental and Craniofacial Research (NIDCR).

Kevin Healy, professor in the College of Engineering, leads Berkeleys research efforts inC-DOCTOR. Other C-DOCTOR partners include UC San Francisco, University of Southern California, UC Davis, UCLA and Stanford. C-DOCTOR is seeking to establish industry partnerships, identify important clinical applications and evaluate mature tissue-regeneration technologies.

The College of Engineering has had a long history in the area of tissue engineering and regenerative medicine, Healy said. Faculty in the departments of bioengineering and materials science are at the forefront of cutting-edge research that will have a transformative impact on craniofacial tissue engineering. The C-DOCTOR funding provides the facilities and resources to support their activity, providing what is necessary to explore interdisciplinary collaborations to achieve the translational goals of the center.

For more on how UC Berkeley is working to treat craniofacial disorders, watch the video below about how researchers here have discovered molecules that give hope for treatingTreacher Collins Syndrome.

See the original post here:
Berkeley engineers join $24 million push for craniofacial repair therapies - UC Berkeley

Cardiovascular Magnetic Resonance: Deeper Insights Through Bioengineering: Figure 5 – Video

Posted on by


Cardiovascular Magnetic Resonance: Deeper Insights Through Bioengineering: Figure 5
Figure 5 from the 2013 review by A.A. Young and J.L. Prince, "Cardiovascular Magnetic Resonance: Deeper Insights Through Bioengineering," from the Annual Rev...

By: Annual Reviews Extra

Excerpt from:
Cardiovascular Magnetic Resonance: Deeper Insights Through Bioengineering: Figure 5 - Video

Brief: Anthem Blue Cross is unbrazen as it’s vindictive business practices lay exposed in California

Posted on by

Note: I don't have much time nowadays so I am switching to quick updates on key issues rather than wait till I have time to post in the long form I am used to.

I first came across this article on the erstwhile ducknetweb, and it makes for an incredible read. I generally do not like reproducing other peoples' hard work as a blog post, but I think Anthem Blue Cross's vindictive business could use all the bad publicity it can get, especially since they plan to appeal a decision against them, rather than apologize to the victims, including the Doctor they rejected from their network and the several patients on whose behalf he fought with Anthem Blue Cross.

Jeffrey Nordella, a doctor who doubled as a patient advocate stood up against Anthem Blue Cross when they rejected patient claims. He put up a brave fight, and in return Anthem Blue Cross barred him from participating in their network. The Supreme Court of California had clearly stated in a 2000 case that when insurance companies kick doctors out of their network, they must give them due process.

Such minor details or a clear verdict from a jury are of no consequence to Anthem Blue Cross apparently. Read for yourself.

I am going to post the links here, and I hope that you will go through them, read and understand what happened here, and, if you happen to be in a similar situation, you will be ready for a long fight!

Links:

1. http://ducknetweb.blogspot.com/2013/04/doctor-wins-38-million-dollar-law-suit.html

2. http://www.latimes.com/business/la-fi-anthem-doctor-verdict-20130410,0,2796259.storySource:
http://chaaraka.blogspot.com/2013/04/brief-anthem-blue-cross-is-unbrazen-as.html

Bioinformatics and Bioengineering – Todd McDevitt, Georgia Institute of Technology – NSF – Video

Posted on by


Bioinformatics and Bioengineering - Todd McDevitt, Georgia Institute of Technology - NSF
Stem cell biomanufacturing is the conduit for fundamental scientific discoveries about stem cell biology to be translated into biomedical diagnostics and therapies. Robust new approaches to control the expansion and differentiation of stem cells in a scalable manner are required for cell production purposes. In addition, non-destructive means of assaying cell fate are needed to introduce feedback control processes and ensure the safety and efficacy of stem cell-derived products. These objectives are being met by the research currently being carried out by Stem Cell Biomanufacturing IGERT trainees at Georgia Tech who are preparing to become the scientific leaders of this rapidly emerging field that exists at the crossroads of stem cell biology, bioengineering and bioprocessing. Specific research efforts include the development of biomaterials approaches for the culture and delivery of stem cells, computational modeling of stem cell fate decisions, label-free non-destructive cell sorting technologies and "real-time" gene expression analysis. Overall, these projects represent the next generation of technologies to be integrated into the biomanufacturing pipeline for the production and ultimately translation of stem cells for biomedical applications.

By: Todd McDevitt

Excerpt from:
Bioinformatics and Bioengineering - Todd McDevitt, Georgia Institute of Technology - NSF - Video